Nostrum Biodiscovery is scaling its computational drug discovery platforms using an HPC cluster and cloud environment.
Published
Signal category
Operations & Supply
Quote
“Our HPC cluster and cloud environment are what let our scientists run at the speed and scale this field demands.”
— Marie-Eve Beaulieu|Nostrum Biodiscovery team
Company
Nostrum Biodiscovery
Rethink and Accelerate
- Industry
- Biotechnology
- Location
- Barcelona, ES
- Company size
- 45 employees
Nostrum Biodiscovery is a spin-off from the Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB), two of the most recognized Spanish international research centers. Nostrum Biodiscovery provide advanced technologies in Molecular Modelling, with two areas of focus : therapeutics, e.g. small molecules design, targeted protein degradation, antibodies, immunologics and nucleic acids, and bio-based chemistry as in enzyme engineering. Nostrum Biodiscovery’s customer-tailored solutions are based on state-of-the-art proprietary and 3rd-party software, combined with the latest development on AI. We use best in-class Molecular Modeling for data augmentation and fine-tuning of dedicated machine-learning algorithms. With a focus on efficiency, innovation, and accessibility, Nostrum Biodiscovery is committed to providing cutting-edge solutions to the global scientific community. We have now clients in more than 13 countries and are currently expanding in Asia, Latin America while strengthening our presence in the US and Europe.
Founded 2015